BANK OF MONTREAL /CAN/ - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 70 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$321,297
-91.3%
6,444
-90.6%
0.00%
-100.0%
Q2 2022$3,696,000
-59.3%
68,437
-44.4%
0.00%
-50.0%
Q1 2022$9,084,000
+84.7%
123,165
+212.9%
0.00%
+33.3%
Q4 2021$4,917,000
-16.0%
39,361
-7.2%
0.00%0.0%
Q3 2021$5,853,000
+1642.0%
42,423
+1818.7%
0.00%
Q2 2021$336,000
+63.1%
2,211
-21.5%
0.00%
Q1 2021$206,000
-67.3%
2,817
-67.5%
0.00%
Q4 2020$630,000
+1025.0%
8,656
+221.5%
0.00%
Q3 2020$56,000
-84.0%
2,692
-81.1%
0.00%
Q2 2020$350,000
+11566.7%
14,268
+5408.9%
0.00%
Q1 2020$3,000
-96.1%
259
-95.1%
0.00%
Q4 2019$77,000
+48.1%
5,258
+32.8%
0.00%
Q3 2019$52,000
-17.5%
3,958
+3.5%
0.00%
Q2 2019$63,000
+384.6%
3,824
+406.5%
0.00%
Q1 2019$13,000
+116.7%
755
+61.3%
0.00%
Q4 2018$6,000
-80.0%
468
-54.5%
0.00%
Q3 2018$30,000
+7.1%
1,029
-0.7%
0.00%
Q2 2018$28,000
+366.7%
1,036
+245.3%
0.00%
Q1 2018$6,000
-76.0%
300
-76.9%
0.00%
Q4 2017$25,000
-83.9%
1,300
-79.3%
0.00%
Q3 2017$155,000
+22.0%
6,284
-20.7%
0.00%
Q2 2017$127,000
+1170.0%
7,922
+1031.7%
0.00%
Q1 2017$10,000
-16.7%
700
-9.4%
0.00%
Q4 2016$12,0000.0%773
+10.4%
0.00%
Q3 2016$12,0007000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 752,024$100,884,00018.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 420,859$56,458,0004.40%
Discovery Value Fund 922,411$123,741,0003.63%
MPM BioImpact LLC 162,620$21,815,0003.38%
Ally Bridge Group (NY) LLC 65,000$8,720,0002.56%
ARK Investment Management 6,743,556$904,648,0002.17%
Integral Health Asset Management, LLC 50,000$6,708,0001.93%
Yorktown Management & Research Co Inc 18,300$2,455,0001.85%
Interchange Capital Partners, LLC 8,191$1,098,0001.84%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$14,950,0001.76%
View complete list of INTELLIA THERAPEUTICS INC shareholders